Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals—The Case of Simvastatin

Justyna Knapik-Kowalczuk, Daniel Kramarczyk, Krzysztof Chmiel, Jana Romanova, Kohsaku Kawakami, Marian Paluch

Open source

DOI
10.3390/pharmaceutics12040384
Published
2020-04-22
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics12040384,
  title = {Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals—The Case of Simvastatin},
  author = {Justyna Knapik-Kowalczuk and Daniel Kramarczyk and Krzysztof Chmiel and Jana Romanova and Kohsaku Kawakami and Marian Paluch},
  year = {2020},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics12040384},
  url = {https://doi.org/10.3390/pharmaceutics12040384}
}

RIS

TY  - JOUR
TI  - Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals—The Case of Simvastatin
AU  - Justyna Knapik-Kowalczuk
AU  - Daniel Kramarczyk
AU  - Krzysztof Chmiel
AU  - Jana Romanova
AU  - Kohsaku Kawakami
AU  - Marian Paluch
PY  - 2020
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics12040384
UR  - https://doi.org/10.3390/pharmaceutics12040384
ER  - 

APA

Knapik-Kowalczuk, J., Kramarczyk, D., Chmiel, K., Romanova, J., Kawakami, K., & Paluch, M. (2020). Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals—The Case of Simvastatin. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12040384

Source records